Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
MiNK Therapeutics Inc
Swot
MiNK Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
MiNK Therapeutics Inc has 23 Strengths, 10 Weaknesses, 1 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(23)
Weakness
(10)
Opportunity
(1)
Threats
(1)
Others
(0)
High Momentum - Stocks with Highest Trendlyne Momentum Score
Rising Momentum: Momentum Score Weekly Gainers
High Normalized Momentum Score
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over Half Year (6 Months)
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Stock gained more than 20% in one month
Annual Net Profits improving for last 2 years
Stock with Low PE (PE < = 10)
RSI indicating price strength
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter
Negative Breakdown First Support (LTP < S1)
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Highest fall from 52 Week High
Biggest Price Losers from Open
Top Losers
Negative Breakdown First Support (LTP < S1)
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Declining profits every quarter for the past 2 quarters
Top Losers
Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts
MFs decreased their shareholding last quarter
